| Primary HPV-based Cervical Cancer Screening Algorithms in Botswana (NCT04242823) | Beth Israel Deaconess Medical Center | 2021-02-22 |
| AdvanTIG-202: Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Previously Treated Recurrent or Metastatic Cervical Cancer (NCT04693234) | BeiGene | 2021-02-15 |
| India HIV-CervCa Project (NCT07167069) | Abramson Cancer Center at Penn Medicine | 2021-02-09 |
| Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) (NCT04704908) | Jun Zhang | 2021-02-06 |
| Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study (NCT04583254) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-02-04 |
| Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. (NCT03061435) | Dr. Danielle Vicus | 2021-02-01 |
| Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients (NCT04038619) | M.D. Anderson Cancer Center | 2021-02-01 |
| Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery (NCT04733820) | Huazhong University of Science and Technology | 2021-02-01 |
| Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline (NCT04723875) | Huazhong University of Science and Technology | 2021-01-28 |
| A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination (NCT03856437) | University of Maryland, College Park | 2021-01-22 |
| Comparison of the Accuracy of US, MRI and PET/CT in the Assessment of LNs in Cervical Cancer. (NCT05573451) | General University Hospital, Prague | 2021-01-20 |
| The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103) (NCT04555226) | Chongqing University Cancer Hospital | 2021-01-11 |
| mHealth-supported Telecolposcopy for Cervical Cancer Programs in Low-resource Settings: Evaluation (mIVAA) (NCT04421131) | Duke University | 2021-01-08 |
| Cervical Cancer Screening Uptake: A Randomised Controlled Trial Assessing the Effect of Sending Invitation Letters to Nonadherent Women (NCT04689178) | Nantes University Hospital | 2021-01-08 |
| Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV (NCT04974424) | Huazhong University of Science and Technology | 2021-01-01 |
| Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer (NCT05084677) | Tianjin Medical University Cancer Institute and Hospital | 2021-01-01 |
| Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer (NCT04641728) | Saitama Medical University International Medical Center | 2021-01-01 |
| Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique (NCT05359016) | M.D. Anderson Cancer Center | 2020-12-22 |
| Mechanisms and Biomarkers for Tumor Immunogenicity Modulation in Cervical Cancer (NCT05188716) | Chuangzhen Chen | 2020-12-10 |
| Biomarkers for Clinical Hypoxia Evaluation in Cervical Cancer (NCT05029258) | University of Manchester | 2020-12-10 |
| Pembrolizumab and Olaparib in Cervical Cancer Patients (NCT04483544) | Baptist Health South Florida | 2020-12-03 |
| Increasing Cervical Cancer Screening Uptake Among Emergency Department Patients (NCT04374760) | University of Rochester | 2020-12-03 |
| Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer (NCT04516616) | Huazhong University of Science and Technology | 2020-12-01 |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial (NCT04679675) | Kaiser Permanente | 2020-11-20 |
| A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation (NCT04141449) | Brigham and Women's Hospital | 2020-11-18 |
| HPV-based Screening Among Women 23-29 Years of Age (NCT05229679) | Karolinska Institutet | 2020-11-16 |
| Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (NCT04644068) | AstraZeneca | 2020-11-12 |
| Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS) (NCT04492007) | UNC Lineberger Comprehensive Cancer Center | 2020-11-02 |
| Distress In CErvical Cancer Patients and Partners (NCT04475354) | Comprehensive Cancer Centre The Netherlands | 2020-11-01 |
| Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046) (NCT04551950) | EMD Serono Research & Development Institute, Inc. | 2020-10-19 |
| Southeast Asian Women's Health Project (NCT04086771) | Ohio State University | 2020-10-16 |
| Detecting HPV DNA in Anal and Cervical Cancers (NCT04857528) | University of Chicago | 2020-10-06 |
| Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India (NCT04588402) | International Agency for Research on Cancer | 2020-10-01 |
| Long-Term Follow-Up of HPV FOCAL Participants (NCT04185389) | University of British Columbia | 2020-09-30 |
| A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers (NCT04260802) | Ocellaris Pharma, Inc. | 2020-09-24 |
| QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer (NCT04864782) | Qilu Pharmaceutical Co., Ltd. | 2020-09-23 |
| Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT05372016) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-09-19 |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC (NCT04140526) | OncoC4, Inc. | 2020-09-16 |
| Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) (NCT04537156) | Xiamen University | 2020-09-05 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors (NCT04242199) | Incyte Corporation | 2020-09-04 |
| CASUS: Validation for Detection of Precursor Lesions (NCT04530201) | Universiteit Antwerpen | 2020-08-20 |
| AN0025 and Pembrolizumab Combination in Advanced Solid Tumors (NCT04432857) | Adlai Nortye Biopharma Co., Ltd. | 2020-08-20 |
| First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours (NCT04504669) | AstraZeneca | 2020-08-18 |
| The Effect of the Program on the Awareness of Roma Women on Cervical Cancer (NCT04756440) | Ondokuz Mayıs University | 2020-08-15 |
| The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples (NCT04423679) | George Washington University | 2020-08-15 |
| HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers (NCT04432597) | National Cancer Institute (NCI) | 2020-08-11 |
| Neoadjuvant Chemotherapy in Cervical Cancer (NCT05384366) | Banaras Hindu University | 2020-08-01 |
| Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors (NCT04556669) | Hebei Senlang Biotechnology Inc., Ltd. | 2020-08-01 |
| Mindfulness in Endometrial and Cervical Cancer (NCT04512144) | St. Louis University | 2020-07-25 |
| Nabothian Cyst Protects or Facilitates Against Cervical Cancer (NCT04488991) | Haseki Training and Research Hospital | 2020-07-23 |
| Gyn Onc Prehab Study (NCT04298827) | St. Louis University | 2020-07-21 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842) | Quadriga Biosciences, Inc. | 2020-07-20 |
| Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer (NCT04016142) | Centre Oscar Lambret | 2020-07-15 |
| Multimodality Treatments of HPV-related Lesions of the Female Genital Tract (NCT05938192) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-07-15 |
| Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer (NCT05220033) | Rutgers, The State University of New Jersey | 2020-07-14 |
| Clinical Validation of Cervical Cancer Screening Methods (NCT04783649) | N.N. Petrov National Medical Research Center of Oncology | 2020-07-13 |
| Safety of Minimally Invasive Surgery Using Endoscopic Stapler in Early Stage Cervical Cancer Patients (SOLUTION) (NCT04370496) | Seoul National University Hospital | 2020-07-02 |
| Orcellex® Brush Versus Cervex-Brush® on Vault Smear Adequacy in Patients Treated With Radiotherapy for Cervical Cancer (NCT04461574) | Princess Margaret Hospital, Hong Kong | 2020-07-01 |
| Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer (NCT04405349) | Nykode Therapeutics ASA | 2020-07-01 |
| A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer (NCT04300647) | Hoffmann-La Roche | 2020-06-30 |
| HPV-Based Screen-and-Treat Demonstration Project in Lilongwe (NCT04092257) | UNC Lineberger Comprehensive Cancer Center | 2020-06-24 |
| HPV Serum Level and FDG PET CT in Patients With Cervical Cancer Treated With Radical Radiochemotherapy (NCT04683549) | The Greater Poland Cancer Centre | 2020-06-15 |
| Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies (NCT04287868) | National Cancer Institute (NCI) | 2020-06-09 |
| Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors (NCT04301011) | Turnstone Biologics, Corp. | 2020-06-02 |
| Effect of Different Treatments on the Prognosis of Early Cervical Cancer: A Multicenter, Prospective, Real-world Study (NCT04272190) | Southern Medical University, China | 2020-06-01 |
| Biop System's Safety and Performance (NCT04232865) | BIOP Medical | 2020-06-01 |
| A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer (NCT04254107) | Seagen Inc. | 2020-05-29 |
| Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04425291) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-05-28 |
| The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer (NCT04409860) | Chongqing University Cancer Hospital | 2020-05-26 |
| Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC (NCT04275713) | Oslo University Hospital | 2020-05-22 |
| Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer (NCT04395612) | Chongqing University Cancer Hospital | 2020-05-08 |
| Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer. (NCT04368273) | Peking University Third Hospital | 2020-05-08 |
| Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female (NCT05426148) | Xiamen Innovax Biotech Co., Ltd | 2020-05-01 |
| Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men (NCT04154358) | Augusta University | 2020-05-01 |
| Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04422366) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-04-28 |
| Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer (NCT04230954) | University of South Alabama | 2020-04-16 |
| Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study (NCT04214964) | Tongji Hospital | 2020-04-11 |
| Gynecologic Brachytherapy-Specific Educational Video (NCT04363957) | University of California, San Diego | 2020-04-01 |
| A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy (NCT04150575) | Shanghai Henlius Biotech | 2020-03-10 |
| Prevention of Cervical Cancer Through an HPV-based Screen-and-treat Strategy in Malawi (NCT04286243) | University of North Carolina, Chapel Hill | 2020-03-04 |
| Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients (NCT04165460) | National Institute of Cancerología | 2020-03-02 |
| CTCs in Cervix Cancer (NCT04064515) | NYU Langone Health | 2020-03-02 |
| Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) (NCT04152499) | Klus Pharma Inc. | 2020-02-28 |
| Effects of Centering Pre-operative Counseling on Patient Reported Anxiety (NCT04068675) | Northwestern University | 2020-02-24 |
| Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 2 (NCT06082882) | The University of Texas Health Science Center, Houston | 2020-02-20 |
| Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) (NCT03946358) | Centre Hospitalier Universitaire de Besancon | 2020-02-18 |
| Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel (NCT04237090) | Ciusss de L'Est de l'Île de Montréal | 2020-02-14 |
| Prospective Evaluation of Self-Testing to Increase Screening (NCT03898167) | Baylor College of Medicine | 2020-02-13 |
| FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery (NCT04016389) | University Health Network, Toronto | 2020-02-11 |
| Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer (NCT03856684) | University Hospital, Tours | 2020-02-11 |
| A Multicenter Cancer Biospecimen Collection Study (NCT04510129) | Cofactor Genomics, Inc. | 2020-02-05 |
| Testing an Implementation Science Tool to Increase Cervical Cancer Screening in Mombasa, Kenya (NCT03514459) | University of Washington | 2020-01-29 |
| Deciphering Mechanisms Underlying Cancer Immunogenicity (NCT03958240) | Institut Claudius Regaud | 2020-01-17 |
| Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory (NCT04630327) | Kazakh Medical University of Continuing Education | 2020-01-13 |
| LITT and Pembrolizumab in Recurrent Brain Metastasis (NCT04187872) | University of Florida | 2020-01-10 |
| Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer (NCT04008095) | University Hospital, Brest | 2020-01-08 |
| The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. (NCT04403867) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2020-01-02 |
| The Application of Real-Time Near-infrared Imaging in Gynecological Surgery (NCT04224467) | Chen Chunlin | 2020-01-01 |
| Applying PET/MR in Oncology - a Prospective Project (NCT04158414) | Tel-Aviv Sourasky Medical Center | 2019-11-28 |
| Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors (NCT04116320) | Craig L Slingluff, Jr | 2019-11-21 |